"contraceptive development program nichd contraceptive clinical trials network - female sites" to conduct phase i, II, III or IV contraceptive trials in women, treatment trials of gynecologic…

Active Indefinite Delivery Contract Awarded Last action

Contract number
75N94020D00018
Awardee
Awarding agency
Task orders
2 $188,146 obligated

Award facts

Opportunity
  • RFPNIHNICHDCDP20201 Solicitation number
Combined order value
  • $266,846 Current, with exercised options
  • $282,464 Potential, with all options
Last date to order 89% complete
IDV ceiling 4% used
$5,000,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 18 offers Negotiated Proposal / Quote
Pricing
Cost No Fee

Award details come from SAM.gov/FPDS.

About this IDV

The National Institutes of Health's National Institute of Child Health and Human Development awarded multiple indefinite delivery contracts to establish the Contraceptive Clinical Trials Network for female clinical research sites. Magee-Womens Research Institute and Foundation was awarded contracts under this vehicle to conduct various clinical trials.

Two delivery orders were issued to Magee-Womens Research Institute and Foundation under the Network's contracts. The first was for approximately $69k to conduct a Phase 1 clinical trial of the Ovaprene vaginal device in Pittsburgh, Pennsylvania over one year with no fee. The second was for approximately $110k to provide assistance with protocol review, development and Network activities in Pittsburgh, Pennsylvania from August 2020 to July 2027 with no fee. A subcontract of unspecified value was issued to the University of Pittsburgh for trial support services under the second order.

The purpose of the Network's contracts is to evaluate new female contraceptive drugs and devices through clinical trials Phases I-IV. The delivery orders provide Magee-Womens Research Institute and Foundation personnel, facilities and services to conduct and support such trials with the goal of advancing candidate products and collecting data to support FDA regulatory approval submissions. No set-asides were applied.

Description

"contraceptive development program nichd contraceptive clinical trials network - female sites" to conduct phase i, II, III or IV contraceptive trials in women, treatment trials of gynecologic conditions such as endometriosis or leiomyoma

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $0

Subawards

Subcontractor Amount Awarded
University Of Pittsburgh - Of The Commonwealth System Of Higher Education 75N94020D00018/75N94020F00001-CORE FUNCTIONS ACTIVITIES TO PROVIDE ASSISTANCE IN PROTOCOL REVIEW, PROTOCOL DEVELOPMENT, AND ACTIVITIES ASSOCIATED WITH PAST,… $11,642

Quick answers

Who was awarded contract 75N94020D00018?

75N94020D00018 was awarded to Magee-Womens Research Institute And Foundation by National Institute of Child Health and Human Development (National Institutes of Health) on August 1, 2020.

How much is contract 75N94020D00018 worth?

Orders under 75N94020D00018 have obligated $188,146. Their combined current value, with exercised options, is $266,846. Their combined potential value, with all options, is $282,464. 75N94020D00018's own ceiling is $5,000,000.

How many orders have been placed under contract 75N94020D00018?

2 orders have been placed under 75N94020D00018, the latest on September 28, 2023.

Who can order from contract 75N94020D00018?

75N94020D00018 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75N94020D00018 competed?

The extent of competition for 75N94020D00018 was full and open competition. The government received 18 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV